Wisata Medis di Qionghai 2026

Dr. Li Yanwen is an early leader in functional neurosurgery in China. He is a founder of neurosurgical navigation in the country. He is a Visiting Professor at the University of Turin. His awards include the First Prize of the Shenzhen Science and Technology Progress Award and the Third Prize of the Guangdong Provincial Science and Technology Progress Award.

He specializes in stereotactic and functional neurosurgery. He has over 20 years of experience and has completed more than 10,000 surgical localization procedures for Parkinson’s disease, cerebral palsy, and epilepsy. He is skilled in stereotactic and navigation techniques. His focus includes precision treatment for hard-to-treat cerebral hemorrhage and traumatic brain injury, post-stroke paralysis, Parkinson’s disease, Alzheimer’s disease, and spinal cord injury. He also performs targeted surgery for autism. He studies stem-cell therapies for neurological and autoimmune diseases.

Dr. Luan Tianyan, MD, is Head of Oncology. He was recruited to Hainan Province as a high-level talent. He is a visiting scholar at the Dana-Farber Cancer Institute (USA). He is also Director of the Clinical Research Office at Bozheng Hengda International Hospital. He serves on the standing committees of the Clinical Research Management Committee (Southern Oncology Clinical Research Association), the Immunotherapy Committee (Hainan Provincial Anti-Cancer Association), and the Hainan Province Drug Research Committee.

He has more than 20 years of oncology practice. He provides individualized, comprehensive care for gastrointestinal tumors, lung cancer, and breast cancer. He focuses on pain management, palliative care, and psychological support in advanced cancer. He also works on the clinical use and study of tumor immunotherapy, including personalized mRNA vaccines and CAR-T therapy. He develops and applies proprietary drugs and related technologies.

Dr. Chen Binglai adalah pakar imunologi biologis (MD). Beliau memegang gelar PhD dalam Kedokteran dari Central South University, dengan fokus pada genetika dan integrasi pengobatan Tiongkok tradisional dan Barat. Beliau menyelesaikan pelatihan pascadoktoral di New York University dan University of Bologna. Beliau adalah profesor tamu di Rumah Sakit Zhongshan, Universitas Fudan.

Beliau berafiliasi dengan Program Bakat Shanghai Pujiang dan Program Bakat Distrik Yangpu 3310. Beliau memimpin proyek inovasi “Pengobatan Kanker Berbasis Teknologi Kultur Sel,” yang didukung oleh Program Pujiang.

Beliau memiliki pengalaman praktik onkologi selama bertahun-tahun dan pengalaman luas dalam mengobati tumor ganas. Pekerjaannya berfokus pada penggunaan klinis dan penelitian terapi CAR-T, sel NK, dan sel punca. Beliau menggunakan program percontohan Lecheng untuk memajukan translasi klinis di Tiongkok dan menawarkan rencana perawatan yang dipersonalisasi.